整理 | GLP1减重宝典内容团队6 月 24 日,礼来在 ClinicalTrials.gov 登记了一项名为 TRIUMPH-7 的 III 期临床试验(登记号:NCT07035093),旨在评估其三重激动剂瑞他鲁肽(Retatrutide,代号 LY3437943)在肥胖或超重并患有慢性腰痛患者中的疗效和安全性。据 Insight 数据库,这是全球首次开展 GLP1R/GIPR/GCGR 三...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.